•  
  •  
  •  
  •  

2025-11-25 17:25:21

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Zydus receives final approval from USFDA for Verapamil Hydrochloride Extended-Release Tablets USP, 120 mg, 180 mg and 240 mg
  • Firstsource recognized as a 'Leader' in Digital Operations in ISG Provider LensĀ® 2025
  • Jyoti Ltd secures LOI from GETCO
  • HCLTech signs strategic collaboration agreement with AWS
  • DCW completes 100 years since laying of foundation stone at Dhrangadhra

Keywords Selected:  RDBRasayans

Stock Report

  • RDB Rasayans Limited approves lease of space for warehousing
  • RDB Rasayans Ltd updates on expansion project
  • RDB Rasayans Ltd Q4 FY2023 net profit drops to Rs. 2.37 crore
  • RDB Rasayans Ltd Q3FY23 net profit lower at Rs. 5.75 crores
  • RDB Rasayans Ltd Q3 FY22 profit higher at Rs. 6.64 crores
  • RDB Rasayans Ltd Q2FY22 net profit falls to Rs. 4.53 crore

Latest Post

  • Zydus receives final approval from USFDA for Verapamil Hydrochloride Extended-Release Tablets USP, 120 mg, 180 mg and 240 mg
  • Firstsource recognized as a 'Leader' in Digital Operations in ISG Provider LensĀ® 2025
  • Jyoti Ltd secures LOI from GETCO
  • HCLTech signs strategic collaboration agreement with AWS
  • DCW completes 100 years since laying of foundation stone at Dhrangadhra


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024